|
TW200509946A
|
|
Methods for the amelioration of environmental oxidant stress and the regulation of beneficial genes
|
|
CA2420548A1
|
|
Composition comprising vitamin c and a pyrone or furanone compound
|
|
US6878744B2
|
|
Vitamin C compositions
|
|
US6468980B1
|
|
Methods and compositions for potentiating cancer chemotherapeutic agents
|
|
AU5797899A
|
|
Pulmonary-adminstration of mineral ascorbates
|
|
CA2348565A1
|
|
Methods and compositions for selective cancer chemotherapy
|
|
AU2664799A
|
|
Stable liquid mineral ascorbate compositions and methods of manufacture and use
|
|
HU211459A9
|
|
Compositions and methods for administering therapeutically active compounds
|
|
ES2028546A6
|
|
Procedure for manufacturing a vitamin C composition having enhanced therapeutic activity
|
|
CN1060216A
|
|
The compositions and the application process thereof that contain therapeutical active compound
|
|
US5070085A
|
|
Compositions and methods for administering therapeutically active compounds
|
|
WO9003167A1
|
|
Compositions and methods for administering therapeutically active compounds
|
|
KR940000006B1
|
|
Pharmaceutical active compounds compositions
|
|
AU3572589A
|
|
Compositions and methods for administering vitamin c
|
|
WO9012571A1
|
|
Compositions and methods for administering vitamin c
|
|
US4968716A
|
|
Compositions and methods for administering therapeutically active compounds
|
|
US4822816A
|
|
Compositions and methods for administering vitamin C
|
|
WO8701702A1
|
|
Ascorbic acid derivatives and processes
|
|
AU5012185A
|
|
Ascorbic acid derivatives and processes
|
